Apart from the well-known reproduction, sexual differentiation in humans leads to the distinct behavioral manifestations. For example, the central pain modulation after noxious injury is gender-determined since severe pain is often experienced and reported by the female subjects.[@B1] With regard to the gastrointestinal (GI) tract, gender also plays the distinct role in terms of motility, visceral sensation, pharmacokinetics, pharmacodynamics and drug toxicity etc.[@B2]-[@B5] Accordingly, various functional GI disorders including irritable bowel syndrome (IBS), functional bloating, constipation, functional abdominal pain and pelvic floor dysfunction etc are more prevalent in women than men owing to these gender-determined obvious behaviors.[@B5] Among the gender effect on IBS manifestations, it is already confirmed that the IBS prevalence reported in Western countries is higher in women compared to men, whereas this characteristic has not always been confirmed in Asia studies.[@B5]-[@B7] It is of interest why women would more easily report IBS symptoms meeting IBS diagnostic criteria. Probably, women usually suffer the higher levels of GI and non-GI sensory symptoms despite of similar levels of IBS severity, and their central visceral sensory processing shows a greater activation to anticipate these stimuli.[@B1],[@B8],[@B9] In addition, the gender difference also impacts on the distinct colonic and extra-colonic symptoms, health-seeking behaviors, somatic complaints, sleep quality as well as psychological behaviors including somatization, depression and anxiety etc in IBS subjects.[@B10],[@B11] All these female behavioral characteristics would then confound the IBS manifestations and lead to meet diagnostic criteria more easily. These gender-determined differences also influence the effective IBS therapy using various measures. It is why there is a greater clinical response to serotonergic agents observed in IBS women compared to men.[@B5],[@B12]

Based on the questionnaire distributed to the IBS patients seen in an Iranian outpatient clinic with the obtained results published in this issue, Anbardan et al[@B13] mainly pointed out that IBS women diagnosed by Rome III criteria were usually constipation-predominant, whereas the male counterparts were diarrhea-predominant. In fact, the expected proportional difference did not statistically exist. It is likely due to the small-sample size of the study and the cultural background in terms of economic state, education, medical seeking behavior and convenience etc, which may account for their unexpected observation. However, their particular addressing on the stool form scale of IBS men who obviously passed looser, mushy and watery stool appears to confirm this characteristic IBS subtype manifestation. Actually, this gender difference on IBS subtypes is not new in Asia, and a selected population study in Taiwan already confirmed it.[@B10] The authors have made a contribution in this issue by confirming the gender effect using the new Rome III criteria. Unfortunately, they did not discuss in detail why these IBS women often expressed the constipated bowel symptom. With regard to this putative mechanism, the role of sexual hormones on GI motility and secretion should not be neglected.[@B3] For instance, genistein (a natural phytoestrogen) administration to the male mice resulted in more chloride ion secretion probably resulting in enhanced water secretion.[@B14] However, it remains uncertain whether this gender-determined secretory mechanism is definitely responsible for male IBS patients to exhibit diarrhea-predominant symptom. Alternatively, the slower GI motility of females may result in constipation symptom, eg, the radio-opaque marker based GI transit study for the constipated females pointed out that a Bristol stool form value \< 3 could predict delayed whole-gut transit with a sensitivity of 85% and specificity of 82% and the delayed colonic transit with a sensitivity of 82% and specificity of 83%.[@B15] Besides, menstrual and postmenopausal women may have different GI physiology and pathophysiology. Accordingly, both postmenopausal and menstruating women reported more somatic symptoms than men with IBS. This effect was also obviously observed among the postmenopausal women.[@B16] Since the authors had tried looking for the gender effect on IBS manifestations, the influence of gestation age on female subjects should have been considered during their initial study design. Further addressing on this issue is needed to answer the drawback of this gender study.

The authors never tried to study the associated functional dyspepsia (FD) or reflux disease among the enrolled IBS patients, hence it is unknown why the authors particularly addressed the role of some upper GI symptoms in terms of reflux, nausea, vomiting, anorexia and heartburn among these patients. Surprisingly, the authors indicated that Iranian IBS females almost had 2.7-fold chance to report nausea symptom (49% vs 18.2%, *P* \< 0.001). However , they did not address on why the female IBS patients were more likely to report nausea. In fact, nausea belonged to one of the upper GI dyspeptic symptoms which was not an IBS component no matter what definition was employed. Interestingly, bloating, nausea and early satiety were frequently reported among the dyspeptic women, whereas food regurgitation and heartburn were commonly observed in male subjects.[@B17] The situation of IBS patients to overlap with FD is not uncommon in accordance with various Rome criteria.[@B6] Accordingly, it is also unknown whether these Iranian women with nausea were exactly associated with dyspepsia or FD together. Regarding to gender impact on FD, females also have more chance to develop FD.[@B18] In addition, delayed gastric emptying (GE) in dyspeptic patients is often characterized by female sex, presence of relevant and severe postprandial fullness, nausea and vomiting etc.[@B19] It probably means that nausea in dyspepsia is somewhat linked with poor GE, particularly among the female subjects. Since the female subjects may have a delayed GE, it is reasonable to suggest that some IBS women with delayed GE may easily express nausea symptom as well as the results published in this issue.[@B3],[@B13]

In conclusion, the authors confirmed again that Asian IBS women are likely constipation-predominant, whereas male patients are diarrhea-predominant according to the recorded stool form scale. The additional finding of commonly existed upper GI nausea symptom among IBS women represents the effect of well-known delayed GE already reported in other gender studies.
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